SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-024923
Filing Date
2021-02-17
Accepted
2021-02-17 19:01:18
Documents
2
Period of Report
2021-02-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm216932d3_3.html 3  
1 OWNERSHIP DOCUMENT tm216932d3_3.xml 3 8199
2 EXHIBIT 24.1 tm216932d3_ex24-1.htm EX-24.1 8378
  Complete submission text file 0001104659-21-024923.txt   18059
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2505 MERIDIAN PKWY, SUITE 340 C/O CHIMERIX, INC. DURHAM NC 27713
Business Address
Richardson Linda M (Reporting) CIK: 0001595064 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35668 | Film No.: 21646889